Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection: A Multicenter Prospective Phase 3 Imaging Trial.
Hope TA, Eiber M, Armstrong WR, Juarez R, Murthy V, Lawhn-Heath C, Behr SC, Zhang L, Barbato F, Ceci F, Farolfi A, Schwarzenböck SM, Unterrainer M, Zacho HD, Nguyen HG, Cooperberg MR, Carroll PR, Reiter RE, Holden S, Herrmann K, Zhu S, Fendler WP, Czernin J, Calais J. Hope TA, et al. Among authors: schwarzenbock sm. JAMA Oncol. 2021 Nov 1;7(11):1635-1642. doi: 10.1001/jamaoncol.2021.3771. JAMA Oncol. 2021. PMID: 34529005 Free PMC article. Clinical Trial.
Prospective evaluation of [11C]Choline PET/CT in therapy response assessment of standardized docetaxel first-line chemotherapy in patients with advanced castration refractory prostate cancer.
Schwarzenböck SM, Eiber M, Kundt G, Retz M, Sakretz M, Kurth J, Treiber U, Nawroth R, Rummeny EJ, Gschwend JE, Schwaiger M, Thalgott M, Krause BJ. Schwarzenböck SM, et al. Eur J Nucl Med Mol Imaging. 2016 Nov;43(12):2105-2113. doi: 10.1007/s00259-016-3439-9. Epub 2016 Jun 17. Eur J Nucl Med Mol Imaging. 2016. PMID: 27317482 Clinical Trial.
[11C]Choline PET/CT in therapy response assessment of a neoadjuvant therapy in locally advanced and high risk prostate cancer before radical prostatectomy.
Schwarzenböck SM, Knieling A, Souvatzoglou M, Kurth J, Steiger K, Eiber M, Esposito I, Retz M, Kübler H, Gschwend JE, Schwaiger M, Krause BJ, Thalgott M. Schwarzenböck SM, et al. Oncotarget. 2016 Sep 27;7(39):63747-63757. doi: 10.18632/oncotarget.11653. Oncotarget. 2016. PMID: 27572317 Free PMC article.
68Ga-PSMA-11 PET/CT Interobserver Agreement for Prostate Cancer Assessments: An International Multicenter Prospective Study.
Fendler WP, Calais J, Allen-Auerbach M, Bluemel C, Eberhardt N, Emmett L, Gupta P, Hartenbach M, Hope TA, Okamoto S, Pfob CH, Pöppel TD, Rischpler C, Schwarzenböck S, Stebner V, Unterrainer M, Zacho HD, Maurer T, Gratzke C, Crispin A, Czernin J, Herrmann K, Eiber M. Fendler WP, et al. J Nucl Med. 2017 Oct;58(10):1617-1623. doi: 10.2967/jnumed.117.190827. Epub 2017 Apr 13. J Nucl Med. 2017. PMID: 28408531 Free article. Clinical Trial.
Development of standardized image interpretation for 68Ga-PSMA PET/CT to detect prostate cancer recurrent lesions.
Fanti S, Minozzi S, Morigi JJ, Giesel F, Ceci F, Uprimny C, Hofman MS, Eiber M, Schwarzenbock S, Castellucci P, Bellisario C, Chauvie S, Bergesio F, Emmett L, Haberkorn U, Virgolini I, Schwaiger M, Hicks RJ, Krause BJ, Chiti A. Fanti S, et al. Eur J Nucl Med Mol Imaging. 2017 Sep;44(10):1622-1635. doi: 10.1007/s00259-017-3725-1. Epub 2017 May 23. Eur J Nucl Med Mol Imaging. 2017. PMID: 28536833
Coronavirus SARS-CoV-2: Empfehlungen für die nuklearmedizinische Versorgung in nuklearmedizinischen Kliniken/Abteilungen mit Therapiestation und Praxen, Instituten sowie Ordinationen.
Krause BJ, Bartenstein P, Freudenberg LS, Herrmann K, Jonas G, Luster M, Moka D, Schäfer W, Schwarzenböck SM, Meyer PT. Krause BJ, et al. Among authors: schwarzenbock sm. Nuklearmedizin. 2020 Apr;59(2):e1-e4. doi: 10.1055/a-1147-6722. Epub 2020 Apr 2. Nuklearmedizin. 2020. PMID: 32241030 German. No abstract available.
FDG PET Hybrid Imaging.
Becker J, Schwarzenböck SM, Krause BJ. Becker J, et al. Among authors: schwarzenbock sm. Recent Results Cancer Res. 2020;216:625-667. doi: 10.1007/978-3-030-42618-7_19. Recent Results Cancer Res. 2020. PMID: 32594401 Review.
Evaluation of [68Ga]Ga-PSMA PET/CT for therapy response assessment of [177Lu]Lu-PSMA radioligand therapy in metastasized castration refractory prostate cancer and correlation with survival.
Kurth J, Kretzschmar J, Aladwan H, Heuschkel M, Gummesson A, Bergner C, Kundt G, Hakenberg OW, Krause BJ, Schwarzenböck SM. Kurth J, et al. Among authors: schwarzenbock sm. Nucl Med Commun. 2021 Nov 1;42(11):1217-1226. doi: 10.1097/MNM.0000000000001446. Nucl Med Commun. 2021. PMID: 34424870
Imaging of Prostate Cancer.
Schlemmer HP, Krause BJ, Schütz V, Bonekamp D, Schwarzenböck SM, Hohenfellner M. Schlemmer HP, et al. Among authors: schwarzenbock sm. Dtsch Arztebl Int. 2021 Oct 22;118(42):713-719. doi: 10.3238/arztebl.m2021.0309. Dtsch Arztebl Int. 2021. PMID: 34427180 Free PMC article. Review.
43 results